In particular, HT supplementation prevented early inflammatory processes causally associated with the onset of insulin resistance and steatosis [81], activated transcription factors such as PPAR-α, -γ and Nrf2, and inhibited NF-κB and SREBP-1c as well as their target genes [83,84,85,86]. The gene discussed is NFKB1; the disease is Insulin resistance.